Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250

Autor: Cees J.A. Punt, Egbert Oosterwijk, Agapi Mavridu, Baudewijn W. Hendrickx, Frans H.M. Corstens, Wim J.G. Oyen, Otto C. Boerman, Ernst J. Postema

Publikováno v: Cancer Biotherapy & Radiopharmaceuticals, 21, 3, pp. 263-8
Cancer biotherapy & radiopharmaceuticals, 21(3), 263-268. Mary Ann Liebert Inc.
Cancer Biotherapy & Radiopharmaceuticals, 21, 263-8
ResearcherID

Carbonic anhydrase 9 recognized by chimeric monoclonal antibody cG250 is overexpressed on biliary cancers. The aim of this study was to determine the targeting of radiolabeled cG250 in patients with biliary cancer to explore a potential role of radio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f0b2d46d23a4064d71ea9d44566a0b
https://hdl.handle.net/2066/50387